-+ 0.00%
-+ 0.00%
-+ 0.00%

Vytrus Biotech nine-month 2026 net profit jumps 53% to EUR 3.43 million

PUBT·11/05/2026 07:59:58
Listen to the news
Vytrus Biotech nine-month 2026 net profit jumps 53% to EUR 3.43 million
  • Vytrus Biotech’s unaudited net profit jumped 53% to €3.43 million in the first nine months of 2026.
  • Sales rose 34% to €8.64 million, while the EBITDA margin reached 56.4%.
  • New products Toleroxyl and Hydranode expanded the portfolio into recombinant proteins and microbial fermentation, bringing its technology platforms to three.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vytrus Biotech SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.